Zentalis Pharmaceuticals ZNTL
Zentalis Pharmaceuticals, Inc. · Nasdaq · Pharmaceutical Preparations
$2.06+4.04%close on Oct. 28, 2026 · volume 2.2M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Aug. 14, 2026 | Walters Group with William Thurman Walters, Susan Berkley Walters 10% owner | Bought | 4,335,000 | $3.50 | $15.17 million |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 11 →Other events · Financial statements and exhibits